RecruitingNCT06091319

Florbetaben for Imaging of Vascular Amyloid

Florbetaben for Imaging of Vascular Amyloid: Evaluation of Amyloid Inflammasome Imaging in Carotid and Coronary Arteries in Patients With Unstable Atherosclerosis- A Pilot Study

Sponsor

Ottawa Heart Institute Research Corporation

Enrollment

30 participants

Start Date

Oct 9, 2023

Study Type

OBSERVATIONAL

Conditions

Stroke Acute Coronary Syndrome Transient Ischemic Attack Atherosclerosis of Artery

Summary

The Primary Objective is to determine if a new nuclear tracer (named 18F-Florbetaben) used with nuclear imaging (PET imaging) can detect inflamed plaque in patients with recent ACS or stroke/TIA.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called [18F]-Florbetaben PET and CT imaging for people with acute coronary syndrome, atherosclerosis of artery, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.